Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1675
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2488
    -0.0023 (-0.18%)
     
  • Bitcoin GBP

    50,941.36
    -591.14 (-1.15%)
     
  • CMC Crypto 200

    1,326.35
    -70.19 (-5.03%)
     
  • S&P 500

    5,108.20
    +59.78 (+1.18%)
     
  • DOW

    38,295.72
    +209.92 (+0.55%)
     
  • CRUDE OIL

    83.97
    +0.40 (+0.48%)
     
  • GOLD FUTURES

    2,347.30
    +4.80 (+0.20%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

DNA Microarray Market Report 2023: Increasing Adoption of DNA Microarray for Various Applications Bolsters Growth

Company Logo
Company Logo

Global DNA Microarray Market

Global DNA Microarray Market
Global DNA Microarray Market

Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression, Genotyping), By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global DNA microarray market size is expected to reach USD 3.53 billion by 2030, registering a CAGR of 8.5% from 2023 to 2030.

The DNA microarray market is anticipated to witness exponential growth opportunities owing to technological advancements and rising R&D investments by the leading participants. In addition, the increasing adoption of DNA microarray technologies in various applications such as genetic disease diagnosis, cancer research, and personalized medicine are the leading factors propelling the global market.

Rapid and accurate disease diagnosis is crucial for the appropriate treatment of patients. The recent advances in molecular-level interaction & detection technologies are upgrading clinical diagnostics services by offering novel solutions for diagnosis. Likewise, the recent advancements in diagnostic DNA microarrays have opened new avenues for the market stakeholders. The DNA microarray technique has applications in genotyping, disease diagnosis, detecting abnormalities, and screening nucleotide polymorphisms.

Moreover, the global DNA microarray market is anticipated to witness exponential growth opportunities owing to the increased research funding, rising healthcare costs, technological advancements, and increased demand for the precision and tailored therapeutic solutions. For instance, according to Med City INVEST Precision Medicine, consumers are increasingly aware of the specific therapies, including precision therapy for treating chronic diseases.

In addition, increased investments by the leading players in the production of effective and advanced diagnostic tools and various strategic initiatives undertaken by the market participants are likely to create new avenues for expansion. For instance, in September 2022, Illumina, Inc. announced the launch of the NovaSeq X Series, a next-generation technology product that can produce more than 20,000 genomes per year. In addition, in September 2021, SCHOTT MINIFAB acquired an Arizona-based microarray solutions company. This acquisition is expected to help the company to strengthen its bioscience capabilities in the U.S.

ADVERTISEMENT

Market Dynamics

Market Drivers

  • Increasing Adoption of DNA Microarray for Various Applications

  • Increasing Prevalence of Genetic Disorders and Cancers

  • Growing Research Activities

Market Restraints

  • High Cost Involved in the Sequencing

  • Availability of Cost Effective Alternatives

DNA Microarray Market Report Highlights

  • The oligonucleotide DNA microarrays segment held the largest share owing to its cost-effectivity and higher capability to monitor the expression of every gene in the genome

  • The complementary DNA microarrays segment is anticipated to register the fastest growth rate because of its wide range of applications in polymorphism screening, genomic DNA clones mapping, and gene discoveries

  • The gene expression analysis segment accounted for the largest market in 2022 due to the adopting gene expression in different applications such as clinical diagnostics, drug discovery, microbiology, and other end-use applications

  • Based on end user, the academic & research institute segment dominated the market in 2022, whereas the diagnostic centers segment is anticipated to be the fastest-growing during the forecast period

  • Asia Pacific is expected to exhibit the fastest growth during the forecast period due to the surge in genomic research funding and increasing awareness about the genetic testing in the region.

Key Attributes:

Report Attribute

Details

No. of Pages

150

Forecast Period

2022 - 2030

Estimated Market Value (USD) in 2022

$1835.54 Million

Forecasted Market Value (USD) by 2030

$3530 Million

Compound Annual Growth Rate

8.5%

Regions Covered

Global

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 DNA Microarray Market Variables, Trends, & Scope

Chapter 4 DNA Microarray Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global DNA Microarray Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Complementary DNA microarrays
4.5.2 Oligonucleotide DNA microarrays
4.5.3 Other DNA microarrays

Chapter 5 DNA Microarray Market Segment Analysis, By Application 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Application Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global DNA Microarray Market, by Application, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Gene expression analysis
5.5.2 Genotyping
5.5.3 Others

Chapter 6 DNA Microarray Market Segment Analysis, By End - user, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 End - user Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global DNA Microarray Market, by End - user, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Pharmaceutical and biotechnology companies
6.5.2 Diagnostic centers
6.5.3 Hospitals and clinics
6.5.4 Academic and research institute
6.5.5 Others

Chapter 7 DNA Microarray Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

Chapter 8 DNA Microarray Market - Competitive Analysis

Companies Mentioned

  • QIAGEN

  • Illumina, Inc.

  • Merck KGaA

  • Thermo Fisher Scientific, Inc.

  • BIOMERIEUX

  • Agilent Technologies, Inc.

  • F. Hoffmann - La Roche Ltd.

  • PerkinElmer, Inc.

  • Applied Micro Arrays



For more information about this report visit https://www.researchandmarkets.com/r/3u70sg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900